Showing 961-970 of 10183 results for "".
Is Your Sunscreen Safe?
https://practicaldermatology.com/conferences/scale-2023/is-your-sunscreen-safe/20187/Practical Dermatology magazine's newest editorial advisory board member Christopher Bunick, MD, PhD, shares advice on how to choose benzene-free sunscreens and offers tips on making smarter choices about sun protection.Skin Checks and Patient Education on Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-checks-and-patient-education-on-actinic-keratoses/20132/During skin checks, it's important for dermatologists to educate patients, especially younger ones, about the extent of sun damage and the benefits of field treatments. Anthony Rossi, MD and Vishal Patel, MD discuss their approaches.Blue Light: A Different Take
https://practicaldermatology.com/topics/acne-rosacea/blue-light-a-different-take/20088/Targeted blue light can have beneficial effects on the skin, says Terrence Keaney, MD. He discusses the types of questions he gets from patients about blue light and what the current data show about the efficacy of low-energy at-home blue light treatments, particularly for acne.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitI Invested in One Laser When I Opened My Practice and This is How It Turned Out
https://practicaldermatology.com/topics/general-topics/i-invested-in-one-laser-when-i-opened-my-practice-and-this-is-how-it-turned-out/20017/Medical dermatology is a tough field to scale with numerous competitors in the market but Dr. Joyce Imahiyerobo-Ip found ways to compete. She shares the struggles of starting a new practice and the difficulties of selling aesthetic services as a dermatologist. A key to her success was the Aerolase NManaging Skin Disease in Cancer Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-skin-disease-in-cancer-patients/19927/Skin reactions to cancer therapeutics can lead to difficult-to-manage rashes. Biologics can present an effective, appropriate option, but dermatologists need to know which biologics to select and when. Anisha Patel, MD provides an overview.Hidradenitis Suppurativa: A Prevalent "Rare" Disease
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-prevalent-rare-disease/19926/Beyond recognizing that hidradenitis suppurativa is far more prevalent than once believed, research has also elucidated disease mechanisms, comorbidities, and pain pathways. Haley Naik, MD provides important updates on this previously neglected disease.SARS-CoV-2 and the Skin: Inside the COVID-19 Dermatology Registry
https://practicaldermatology.com/conferences/aad-2021/sars-cov-2-and-the-skin-inside-the-covid-19-dermatology-registry/19921/From COVID Toes to COVID Arms, dermatologic manifestations of SARS-CoV-2 infection and COVID-19 vaccination abound. Esther Freeman, MD, PhD, Director of the COVID-19 Dermatology Registry provides an overview of findings and shares information about the relatively new vaccine registry.Seeing the Individual in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/seeing-the-individual-in-ad-care/19890/The best care for patients with atopic dermatitis requires a holistic approach, suggests Dr. Stephan Weidinger. He discusses strategies to improve the management of this complex diseases and highlights innovative strategies for care identified through the Quality of Care in Atopic Dermatitis initiatTry New Things
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/try-new-things/19690/For the field of aesthetics to move forward, innovation is essential. Brian Biesman, MD discusses a responsible approach to trying new things in the clinical setting and stresses the need for caution at times.